
Debiopharm Innovation Fund
Europe, Vaud, Switzerland, Lausanne
Description
Debiopharm Innovation Fund offers a strategic investments in for companies and businesses.
Investor Profile
Debiopharm Innovation Fund has made 29 investments, with 2 in the past 12 months and 52% as lead.
Stage Focus
- Series A (41%)
- Seed (17%)
- Series C (10%)
- Series B (10%)
- Pre Seed (7%)
- Series Unknown (7%)
- Post Ipo Equity (3%)
- Series E (3%)
Country Focus
- United States (34%)
- Switzerland (24%)
- France (10%)
- Germany (7%)
- United Kingdom (7%)
- Spain (3%)
- Canada (3%)
- Belgium (3%)
- Finland (3%)
- Israel (3%)
Industry Focus
- Health Care
- Biotechnology
- Software
- Life Science
- Pharmaceutical
- Biopharma
- Medical Device
- Artificial Intelligence (Ai)
- Machine Learning
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.